Baxion
Screening
Tags
Alerts
Theme
Verrica Pharmaceuticals Inc.
VRCA
·
NASDAQ
·
$6.02
Share Price as of 11/2
·
$64M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/12/26
10-K
FY 2025
03/11/26
10-Q
Q3 ended 09/30/25
11/14/25
10-Q
Q2 ended 06/30/25
08/12/25
Disclosures
Filter
8-K
Current report
08/06/26
8-K
Current report
06/09/26
8-K
Current report
05/12/26
8-K
Current report
03/11/26
8-K
Current report
12/30/25
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
05/12/26
424B3
Prospectus
12/23/25
S-3
Shelf registration
12/15/25
S-8
Registration of securities for employees
05/13/25
S-3
Shelf registration
03/11/25
Proxies
Filter
DEF 14A
Definitive proxy
04/20/26
DEFA14A
Additional proxy materials
04/20/26
DEFR14A
Definitive proxy (revised)
04/30/25
DEF 14A
Definitive proxy
04/22/25
DEFA14A
Additional proxy materials
04/22/25
Ownership
Filter
Form 4
Insider transaction
08/18/26
Form 4
Insider transaction
08/18/26
Form 4
Insider transaction
08/18/26
Form 4
Insider transaction
08/18/26
Form 4
Insider transaction
06/09/26
Other
Filter
ARS
Annual report to shareholders
04/20/26
EFFECT
Request for effectiveness
12/23/25
CORRESP
Correspondence with the SEC
12/19/25
D
D
12/10/25
ARS
Annual report to shareholders
04/22/25
Latest Filings
Filter
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Current report
08/06/26
8-K
Current report
06/09/26
10-Q
Q1 ended 03/31/26
05/12/26
8-K
Current report
05/12/26
Ownership
Filter
Form 4
Insider transaction
08/18/26
Form 4
Insider transaction
08/18/26
Form 4
Insider transaction
08/18/26
Form 4
Insider transaction
08/18/26
Form 4
Insider transaction
06/09/26